Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim

OBJECTIVES: Eumycetoma is currently treated with a combination of itraconazole therapy and surgery, with limited success. Recently, olorofim, the lead candidate of the orotomides, a novel class of antifungal agents, entered a Phase II trial for the treatment of invasive fungal infections. Here we de...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Wilson, Eadie, Kimberly, Konings, Mickey, Rijnders, Bart, Fahal, Ahmed H, Oliver, Jason D, Birch, Mike, Verbon, Annelies, van de Sande, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069493/
https://www.ncbi.nlm.nih.gov/pubmed/31904836
http://dx.doi.org/10.1093/jac/dkz529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069493/
https://www.ncbi.nlm.nih.gov/pubmed/31904836
http://dx.doi.org/10.1093/jac/dkz529

Ejemplares similares